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Optical Coherence Tomography in 
the Management of Glaucoma and 
Macular Diseases
Lawan Abdu
Abstract
Optical coherence tomography (OCT) is a non contact, non invasive and repro-
ducible imaging technique that produces thin slices of tissue section images. OCT 
identifies retinal nerve fiber damage before detection of visual field changes making 
it a handy and effective tool in early detection and monitoring in glaucoma. Retinal 
fiber layer thickness measurements provide vital knowledge of extent of neural 
damage. This enables the clinician to counsel the patient and take the best decision 
towards achieving glaucoma control. Early and quantifiable macular thickness 
measurements are obtained, allowing for detection of clinically significant diabetic 
macular edema. OCT allows monitoring of the impact of laser or other interven-
tions. Changes in age-related macular degeneration are relatively easily determined 
and impact of treatment interventions monitored. In conclusion, OCT is a vital 
emerging tool in the evaluation and management glaucoma and macular diseases in 
all parts of the World, including low income countries of sub-Saharan Africa.
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1. Introduction
Optical coherence tomography (OCT) is a noninvasive, noncontact, and repro-
ducible investigation. The relatively new technology is comparable to ultrasound that 
utilizes low coherence interferometry to produce cross-sectional images of the retina. 
The functional principle behind OCT imaging is light interference [1]. Infrared light 
from a luminescent diode source is divided into two, one of which is reflected from 
a reference mirror and the other scattered from retinal tissues. The reflected beams 
from the two sources are made to produce interference pattern, thus obtaining the 
echo time delay and their amplitude information which makes up an A-scan. The 
cross-sectional images are generated by measuring the echo time delay and intensity 
of light reflected from internal structures in the retina [2]. Scattering is a property of 
heterogonous medium and arises due to variation in refractive index between tissues 
structures. An interferometric technique analyzes the reflected light signal, and a 
transverse scanning mechanism captures the A-scans from adjoining retinal locations 
to produce a two-dimensional image [3]. OCT produces high-resolution images which 
allows detailed assessment of retinal thickness and morphologic evaluation of retinal 
layers [4]. The image is colored to enhance tissue recognition. There are two models 
described: time domain (TD-OCT) and Fourier domain (FD-OCT). In TD-OCT, 
measurements of the light echoes are detected sequentially by stepwise movement 
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of the reference mirror, while in FD-OCT, the light echoes and the source from all 
axial depth are detected as modulations in the source spectrum simultaneously [5]. 
One of the main differences is the reference mirror in TD-OCT. The moving mirror 
causes inertia and limits mechanical performance of the TD-OCT. Elimination of 
this mechanical translation leads to faster data acquisition speed in FD-OCT. The 
instantaneous current generated in an FD-OCT detection system by incoming light 
is a function dependent on the source wavelength sampled at a particular instance. 
The acquired data is transformed into axial scan information (A-scan) by an inverse 
Fourier transform [6]. Fourier Dormain-OCT consists of two primary methods, 
spectral dormain and swept source OCT. The two variants are abbreviated as SD and 
SS domain OCT, respectively.
The Spectral domain OCT employs principle of Michelson-type interferometry 
that utilizes a static reference mirror. The generated interference signal is detected 
and the dual returning beams are recombined to form an interference pattern 
at the beam splitter. At this point a diffraction grating disperses the beam which 
is detected by a high-speed charge-couple device (CCD) camera. The generated 
interference pattern detected by the line camera produces an array that results 
in obtaining tissue reflectivity as a depth function. The detection rate of the line 
sensor defines the acquisition speed of such systems [7]. Interference patterns are 
dispersed quite rapidly before detection in spectral domain OCT while in the Swept 
source OCT a laser with a limited spectral line within the available bandwidth of the 
source scan the tissues in a regulated way. Subsequently, the mirror reflected refer-
ence beam generates an interference pattern with the light backscattered by the tis-
sue and this is identified by the detector. Point detection is one advantage that swept 
source has over spectral domain OCT because of its higher signal-to-noise ratio 
when compared to line detectors [8]. Fourier domain OCT has reduced artifacts and 
faster scan acquisition time which permits three dimensional image construction 
[9]. High reflectivity tissues are depicted in red, medium yellow to green while low 
appears as blue to black.
The limitations of OCT include poor signal strength in the presence of opacity in 
the ocular media which prevents data acquisition. Patients with macular problems 
that reduced the central vision may have difficulty fixating on the target. Motion 
artifacts can give rise to false observations, and such artifacts are commoner in eyes 
with underlying pathology [10]. The technology is expensive and not available in 
most tertiary hospitals in the sub-Saharan African region. The few available ones 
are mainly located in urban centers away from vast majority in rural communities. 
OCT scan is not covered by the health insurance scheme which in any way is only 
available to the few working in regular public/private sectors.
2. OCT in glaucoma
Glaucoma is the second leading cause of blindness [11]. The standard method of 
diagnosis is based on clinical evaluation of characteristic optic nerve damage and the 
visual field changes detected by standard automated perimetry (SAP). OCT provides 
additional evaluation and assessment for monitoring glaucoma progression thought it 
may not be of much value in patients with advanced disease. Visual field changes are 
not detected in early stages of glaucoma due to the functional overlapping pattern and 
integration of the visual system which compensate for and to some extent mask early 
damage. A 6 mm3 scan centered on the disk provides graphic and quantifiable retinal 
thickness measurements in addition to providing an objective calculation of the cup-
ping by giving details of the extent of vertical cup-to-disk ratio. Effective management 
requires detection of early changes in glaucoma even before development of detectable 
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visual field defects as neural damage may precede visual field defects by many years. 
Significant differences in RNFL thickness have been observed to occur up to 8 years 
before detectable visual field defects [12]. Thus OCT is quite useful in identifying 
changes in retinal nerve fiber layer (RNFL) thickness, the optic nerve head structure 
(ONH), and the macular ganglion cell complex (GCC). A 3.46 mm para-papillary scan 
entered on the optic nerve head evaluates RNFL thickness in all the quadrants and is 
useful in assessment and monitoring of glaucoma progression. In most instances, the 
RNFL thickness is highest in the inferior quadrant followed by superior, nasal, and tem-
poral quadrants in that order (ISNT rule) [13]. Analysis of the RNFL and inner macular 
thickness has provided additional means of determining glaucomatous optic nerve 
damage and progression [14]. There is paucity of normative RNFL data in sub-Saharan 
Africa though some reports indicate an RNFL average of 110 and 104.17 μm, respectively 
[15, 16]. RNFL below 100 μm is suspect, less than 90 μm requires full glaucoma workup, 
and values less than 70 μm are not unusual at the time of glaucoma diagnosis. Reduction 
of the average thickness within certain time frame can be an indicator of progression in 
addition to perimetric changes. Figure 1 shows glaucoma optic nerve damage on OCT.
3. OCT in macular diseases
The macula serves as the most acute visual function, and conventional assess-
ment includes ophthalmoscopy and slit lamp evaluation in conjunction with contact 
and noncontact retinal lenses. Naked eye assessment can however not be compared 
with quantifiable OCT analysis. Fast macular scan protocol can be employed to pro-
vide graphic image of the state of the macula. Macular scan results can be displayed 
as numeric data or as false color display form. Normative data in Africans is not 
largely available though a study indicates macular thickness and volume of 149.58 
and 6.79 μm3, respectively [17]. Central macular thickness above 200 μm is uncom-
mon in healthy eyes and deserves further evaluation even when the vision is not 
significantly affected. Macular thickness measurements in diabetic macular edema 
are based on criteria definition of existing standard protocol. Macular thickness 
measurement below 110 μm is rarely observed in normal eyes. Disorders of the mac-
ula include diabetic maculopathy and other forms of acquired maculopathy such as 
age-related macular degeneration. A survey report indicated diabetic retinopathy 
(DR) to be a cause of blindness and visual impairment despite some patients being 
Figure 1. 
OCT illustration of glaucomatous optic disk cupping.
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unaware of their diabetic status [18, 19]. DR rivals cataract and glaucoma as a 
cause of visual impairment in an institution-based study of diabetic patients [20]. 
Diabetic cystoid macular edema (CME), diffuse thickening, and serous detachment 
can objectively be measured with OCT [21, 22]. OCT demonstrates retinal thicken-
ing and cystoid spaces in the presence of CME. As OCT was not in use during the 
ETDRS, [23] clinically significant macular edema was defined by the presence of 
retinal thickening within 500 μm of fovea or hard exudates within 500 μm of the 
fovea or retinal thickening more than one disk diameter any part of which is within 
a disk diameter of the fovea [24]. OCT has been demonstrated to quantify the extent 
of CSME at diagnosis even more accurately than clinical fundal assessment and can 
serve in determining response to treatment applied. Figure 2 shows a normal OCT 
macular scan, and Figure 3 shows cystoid spaces in macular edema. Likewise OCT 
can be used to monitor resolution of CME with appropriate treatment.
Age-related macular degeneration (ARMD) is a group of primary disorders of the 
retina which are emerging as a significant cause of visual impairment in developed 
countries. With change in lifestyle, the disease is becoming common even in develop-
ing countries though a population survey report showed it was not a significant cause 
of visual impairment [17]. ARMD has been classified into dry (non-exudative) and 
wet (exudative) types. The dry type is the most common, and geographic atrophy 
is the manifestation of the late stage of the disease. The International Age Related 
Figure 3. 
Clinically significant macular edema.
Figure 2. 
OCT showing normal macular scan.
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Maculopathy Epidemiological Study Group (IARMESG) has classified the disease 
further age-related maculopathy (ARM) into early (medium to large drusen, retinal 
pigment epithelium (RP) hyperpigmentation and/or hypopigmentation). Figure 4 
shows drusen on OCT scan. Advanced AMD is characterized by geographic atrophy 
(Figure 5) and/or choroidal neovascularization. SD-OCT has been demonstrated 
to quantify the volume of drusen and thus monitor progression [25]. OCT has 
been demonstrated to be useful in estimating photoreceptor loss, quantifying the 
extent, and providing insight as to the structural damage leading to enlargement 
and progression of geographic atrophy in non-neovascular AMD [26, 27]. Retinal 
pigment epithelium (RPE) detachment arises from dysfunction of the normal 
physiologic factors that ensures its adhesion to Bruch’s membrane. The separation 
occurs between the basement membrane of the RPE and the inner collagenous layer 
of Bruch’s membrane which become thickened and dysfunctional. The separation  
appears as an optically empty space on OCT (Figure 6). OCT can distinguish two 
Figure 4. 
OCT features of macula drusen.
Figure 5. 
OCT features of geographic atrophy (source: www.octscans.com).
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broad types of RPE detachment, thus aiding in making accurate diagnosis [28]. Wet 
AMD is associated with choroidal neovascularization (CNV). The blood vessels arise 
from the choriocapillaris and break through Bruch’s membrane. CNV membrane 
(Figure 7) can remain in the sub RPE or even extend into the subretinal space. Fundal 
fluorescein angiography (FFA) is the primary investigation in diagnosis of suspected 
CNV. The role of OCT is in providing quantifiable monitoring of response to treat-
ment. OCT shows increased thickness and fragmentation of the high reflectivity RPE 
and choriocapillaris. Improvement in data acquisition and 3-D imaging in SD-OCT 
provides more detailed images leading to higher and earlier detection of CNV when 
compared to time-domain technology [29]. Combined OCT angiography provides 
additional value in diagnosis and monitoring of the impact of treatment in wet ARM.
Macular hole is one of the age-related causes of vision loss, and studies have 
shown that macular hole is not uncommon in sub-Saharan Africans [30, 31]. 
Population incidence of 6.8–8.69 has been reported in the Unites States [32]. Occult, 
lamellar, full-thickness holes, and complete posterior vitreous detachment (PVD) 
can accurately be quantified on OCT. Full-thickness hole is identified including 
a pseudo operculum where present. OCT is used for characterization of macular 
Figure 7. 
OCT showing choroidal neovascularization.
Figure 6. 
Retinal pigment epithelial detaachment showing Optically empty space between Bruch’s membrane and 
separated RPE.
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holes and to visualize persistent retinal abnormalities which were observed despite 
achieving anatomical closure [32, 33].
4. Impact of OCT on glaucoma and diabetic macular edema
OCT has aided the ophthalmologist in early detection and provides a more 
objective monitoring tool in glaucoma management in sub-Saharan Africa. This 
is achieved by effective detection of RNFL loss and evaluation of the differential 
measurements in the four quadrants to detect deviation from normal (normal RNFL 
thickness declines measurement in this order: inferior, superior, medial, and temporal 
quadrants—ISN’T rule). OCT RNFL can be utilized alone or better in combination 
with standard automated perimetry in monitoring for stabilization or deterioration of 
glaucomatous optic neuropathy over time. This will enable the clinician to counsel the 
patient using objective criteria and modify the treatment to achieve goal of effective 
glaucoma control. OCT gives accurate central macular thickness measurement and 
thus provides effective and early detection of clinically significant diabetic macular 
edema. The impact of laser and/or intravitreal anti-VEGF on treatment of prolifera-
tive diabetic retinopathy and macular edema can be determined.
5. Conclusion
OCT is still a relatively new technology in the diagnosis and monitoring of glaucoma 
and macular diseases in the region. Older models are available in few centers and clini-
cians have limited access. By the poor income of most sub-Saharan Africans, OCT scan is 
expensive. Most of the machines have no provision for digital data retrieval, thus making 
research work on impact of the technology more difficult. Normative data on various 
parameters have to be locally generated in order to make more objective decision when 
there is variation from normal. In few countries with limited health insurance services 
(which only cover workers in the national public service), OCT is exempted as has to be 
paid for as out-of-pocket expense, thus further limited access to the vast population. A 
public-private partnership could enhance availability to the underserved population.
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